Kathleen Kelly
Affiliations: | Cell and Cancer Biology Branch | National Cancer Institute - NIH |
Google:
"Kathleen Kelly"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Beshiri ML, Capaldo BJ, Lake R, et al. (2024) Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate resistant prostate cancer. Stem Cells (Dayton, Ohio) |
| Agarwal S, Fang L, McGowen K, et al. (2023) Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models. The Journal of Clinical Investigation |
| Beshiri M, Agarwal S, Yin JJ, et al. (2023) Prostate organoids: emerging experimental tools for translational research. The Journal of Clinical Investigation. 133 |
| Whitlock NC, White ME, Capaldo BJ, et al. (2022) Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A. Discover. Oncology. 13: 97 |
| Fang L, Li D, Yin J, et al. (2022) TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence. Cancer Gene Therapy |
| Roy J, White ME, Basuli F, et al. (2021) Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [F]DCFPyL PET Imaging. Molecular Imaging and Biology |
| Baca SC, Takeda DY, Seo JH, et al. (2021) Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer. Nature Communications. 12: 1979 |
| Adelaiye-Ogala R, Gryder BE, Nguyen YTM, et al. (2020) Targeting the PI3K/AKT pathway overcomes enzalutamide resistance by inhibiting induction of the glucocorticoid receptor. Molecular Cancer Therapeutics |
| Kelly K. (2020) Profiling prostate biology. Science (New York, N.Y.). 368: 467-468 |
| Hwang JH, Seo JH, Beshiri ML, et al. (2019) CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer. Cell Reports. 29: 2355-2370.e6 |